You track your fasting glucose, ApoB, hs-CRP, and HRV trend lines. But some of the most durable signals in aging research aren't on a blood panel at all—they're how hard you can breathe, how hard you can squeeze, and how slowly your heart idles.
Why functional markers complement your labs
Blood panels tell you about the chemistry of aging at a single moment. Functional markers tell you about the *integrated output* of multiple systems over time—cardiovascular, mitochondrial, neuromuscular, and autonomic. For someone who already exports sleep and HRV data into spreadsheets, these are the variables that explain why two people with similar lipid panels can age very differently.
The Velri physician team treats these markers as a layer on top of lab work, not a replacement for it. A normal metabolic panel paired with a declining VO2 max or grip trend is a different clinical conversation than either data point alone. This article is educational and not medical advice; how any marker applies to you is something to discuss with an independent licensed provider.
VO2 max: the most studied fitness-mortality signal
VO2 max—the maximum rate your body can use oxygen during intense exercise—is among the most heavily studied predictors of all-cause mortality in the cardiorespiratory literature. A large retrospective cohort of over 122,000 patients undergoing exercise treadmill testing found a graded, inverse relationship between cardiorespiratory fitness and mortality across all age groups and both sexes, with no observed upper limit of benefit in the data [1]. The American Heart Association formally recognized cardiorespiratory fitness as a clinical vital sign, arguing it should be assessed alongside traditional risk factors [2].
For a quantified-self engineer, the practical nuance is *estimation versus measurement*. Wrist and ring devices estimate VO2 max from heart-rate-to-pace relationships; a graded exercise test with gas exchange (CPET) measures it directly. The estimate is useful for tracking your own trend; the measured value is what a clinician can anchor against population reference data. Both are more meaningful as a slope over months than as a single number.
Source: [1] Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing (JAMA Network Open), [3] Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study (The Lancet), [4] Resting heart rate and all-cause and cardiovascular mortality: a dose-response meta-analysis (CMAJ)
Grip strength: a proxy for whole-body resilience
Grip strength is a deceptively simple measurement—a handheld dynamometer—that correlates with broader muscular strength and serves as a marker of overall physiological reserve. In the international PURE study spanning nearly 140,000 participants across 17 countries, lower grip strength was associated with higher all-cause mortality and cardiovascular events, and each reduction in grip strength tracked with meaningful changes in risk after adjustment [3]. Grip is attractive precisely because it's cheap, reproducible, and trackable over time—exactly the kind of metric that fits a self-quantification workflow.
The mechanism story matters here: grip is a window into sarcopenia (age-related muscle loss) and neuromuscular integrity. It's not that strong hands extend life; it's that grip is a readout of muscle quality and the systems that maintain it. Tracking it quarterly alongside your training logs gives a clinician a tangible resilience trend to interpret.
Resting heart rate and autonomic balance
Resting heart rate (RHR) reflects autonomic tone—the balance between your sympathetic ("go") and parasympathetic ("recover") nervous systems. A meta-analysis of cohort studies covering over one million participants reported that higher resting heart rate was associated with increased risk of all-cause and cardiovascular mortality, with risk rising progressively above roughly the mid-60s beats-per-minute range [4]. Your ring already captures nightly RHR; the value to a clinician is the multi-week baseline and how it moves with training load, illness, alcohol, and sleep debt.
RHR is also where your HRV data becomes more interpretable. The two are related expressions of autonomic state, and a physician reading them together with your training context can separate "productive fatigue" from "systemic strain."
Orthostatic response: the overlooked autonomic test
Orthostatic response—how your heart rate and blood pressure adjust when you move from lying to standing—is a quick autonomic stress test. Clinically, a sustained drop in systolic blood pressure of at least 20 mmHg (or 10 mmHg diastolic) within three minutes of standing defines orthostatic hypotension, a finding linked in consensus statements to autonomic dysfunction and cardiovascular risk [5]. For an optimizer, an exaggerated or blunted orthostatic response can be an early, low-cost signal worth flagging—context that pairs naturally with the morning RHR your wearable already records.
How a physician synthesizes the picture
None of these markers is diagnostic in isolation. Their value is in the pattern. A provider building a fuller picture of biological aging looks at:
- Trajectory over single values — slopes of VO2 max, grip, and RHR across months.
- Concordance with labs — does a rising RHR line up with inflammatory markers or thyroid data?
- Context — sleep, training load, alcohol, and stress that explain short-term noise.
- Modifiable levers — where structured training, recovery, or further workup may be reasonable next steps, decided with you.
This is the relationship many self-quantifiers are missing: not a clinician who says "just exercise more," but one who reads your exported data against validated reference frames and helps you decide what to measure next. Where any intervention—including peptides or other prescription therapies—enters the conversation, it is evaluated against your labs and history by an independent licensed provider, and a prescription is never guaranteed.
mmHg systolic drop within 3 min of standing · marker = Definition
A note on therapies and sourcing
If you're coming from gray-market sourcing, the relevant shift is oversight and provenance: knowing what's in a product and who reviewed your labs before anything is considered. Some longevity-oriented therapies are available only as compounded preparations. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state. Whether any therapy is appropriate is a clinical decision made with an independent provider—not something these markers alone determine.
Where Velri fits
Velri is a technology and coordination company; it does not provide medical care. Velri can help coordinate the practical layer around these markers: arranging lab work, connecting you with an independent licensed provider who can review your panels and the functional data you already track, and—if that provider determines it's appropriate and writes a prescription—coordinating fulfillment through an independent licensed pharmacy. Care is delivered by independent provider groups; medications are dispensed by independent pharmacies. The aim is a physician-directed, lab-informed picture you're not assembling alone. This article is educational and is not medical advice.
